论文部分内容阅读
美国免疫实施咨询委员会(Advisory Committee on Immunization Practices,ACIP)每年都公布免疫程序,该免疫程序汇总了推荐用于≤18岁人群目前已批准的疫苗,以及至2011年12月23日仍在使用的疫苗的预防接种建议。与之前的免疫程序相比,变化如下:1.表1(美国2012年推荐的≤6岁儿童免疫程序)更新内容。4价脑膜炎球菌结合疫苗(Quadrivalent Meningococcal Conjugate Vaccine,MCV4)因4价脑膜炎球菌-白喉内毒素结合疫苗[MCV4-Diphtheria,MCV4-D(Menactra)]已批准用于9月龄儿童,紫色格子扩大到9月龄。甲型肝炎(甲肝)疫苗(Hepatitis A Vaccine,HepA)黄色格子进1HepA2
The Advisory Committee on Immunization Practices (ACIP) publishes an annual immunization schedule that summarizes the current recommended vaccines for people ≤18 years of age and those still in use until December 23, 2011 Vaccination vaccination advice. Compared with the previous immunization program, the changes are as follows: 1. Table 1 (the United States in 2012 recommended 6-year-old children immunization program) updates. Quadrivalent Meningococcal Conjugate Vaccine (MCV4) has been approved for use by 9-month-old children due to a 4-valent meningococcal-diphtheria endotoxin conjugate vaccine [MCV4-Diphtheria, MCV4-D Expand to 9 months old. Hepatitis A Vaccine (HepA) Yellow plaid into 1HepA2